Latest Thermo Fisher Scientific News & Updates

See the latest news and media coverage for Thermo Fisher. We track all announcements, press releases, and industry mentions in real time, all in one place.

Thermo Fisher Scientific (Thermo Fisher)

Life sciences tools, technology, and services provider

thermofisher.com

Headquarters: Waltham, United States
Company type: Public company
Number of employees: 95,000+
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Thermo Fisher Scientific (Thermo Fisher)

In short: Thermo Fisher reported strong Q2 2026 growth, set a long-term 7% organic growth target, and sold its microbiology business for $1.075B.

Company announcements

September 15 Thermo Fisher

Thermo Fisher and Mayo Clinic launch Precure LLC

They create a major biomedical dataset with AI analytics to study disease biology, drug development, and early diagnosis.

August 12 Thermo Fisher

Thermo Fisher sells microbiology business to Astorg for $1.075 billion

The deal includes a $50 million seller note and follows the division's $645 million revenue generation in 2025 within the Specialty Diagnostics segment.

July 27 Thermo Fisher

Thermo Fisher presents diagnostic solutions at ADLM 2026

The press release highlights FDA clearances for EXENT multiple myeloma test and EliA CTD 13 screen, plus LabLink360 software.

July 24 Thermo Fisher

Thermo Fisher launches InstaFlux for food microbiology labs

The media-on-demand workflow simplifies media preparation and supports traceable enrichment testing.

Media coverage

September 15 Yahoo Finance

Thermo Fisher CEO Says AI Will Drive More Pharma Spending — Sees 7% Organic Growth By 2028

In an interview with CNBC on Tuesday, Marc Casper said AI is helping drugmakers identify ineffective...

September 9 Marketscreener

UBS Upgrades Thermo Fisher Scientific to Buy From Neutral, Adjusts Price Target to $730 From $540

Thermo Fisher Scientific has an average rating of overweight and mean price target of $650.38, according to analysts polled by FactSet.

September 7 Traders Union

Thermo Fisher leans on deals and biotech rebound as growth regains pace

Thermo Fisher Scientific pivots to biotech deals and rebounds as growth accelerates post-pandemic, despite weaker U.S. and ...

August 19 Yahoo Finance

Q2 Earnings Highs And Lows: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

The end of the earnings season is always a good time to take a step back and see who shined (and who didn't). Let's take...

Never miss news about Thermo Fisher

Track Thermo Fisher and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Thermo Fisher competitors & trending companies

Browse news for competitors to Thermo Fisher and other trending companies.